Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention

Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention

<i>Background and Objectives</i>: Remote ischemic preconditioning (RIPC) has demonstrated efficacy in protecting against myocardial ischemia–reperfusion injury when applied before percutaneous coronary revascularization. Ranolazine, an anti-ischemic drug, has been utilized to minimize is...

Full description

Bibliographic Details
Main Authors: Konstantinos Kourtis, Angeliki Bourazana, Andrew Xanthopoulos, Spyridon Skoularigkis, Emmanouil Papadakis, Sotirios Patsilinakos, John Skoularigis
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Medicina
Subjects:
ranolazine
preconditioning
cardioprotection
percutaneous
coronary
intervention
Online Access:https://www.mdpi.com/1648-9144/60/1/166

Internet

https://www.mdpi.com/1648-9144/60/1/166

Similar Items